cetylpyridinium has been researched along with Alveolar Bone Atrophy in 1 studies
Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Waal, YC | 1 |
| Raghoebar, GM | 1 |
| Huddleston Slater, JJ | 1 |
| Meijer, HJ | 1 |
| Winkel, EG | 1 |
| van Winkelhoff, AJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical and Microbiological Evaluation Implant Surface Decontamination With 2% Chlorhexidine in the Surgical Treatment of Peri-implantitis; a Double Blind Controlled Randomized Clinical Study[NCT01852253] | 44 participants (Actual) | Interventional | 2010-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for cetylpyridinium and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Implant decontamination during surgical peri-implantitis treatment: a randomized, double-blind, placebo-controlled trial.
Topics: Alveolar Bone Loss; Anti-Infective Agents, Local; Bacteria, Anaerobic; Cetylpyridinium; Chlorhexidin | 2013 |